What Is Ascentage Pharma Group Internat (AAPG) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Ascentage Pharma Group Internat's intrinsic value is estimated at $11.67, suggesting the stock is overvalued at its current price of $19.62. With 9 out of 12 models flagging downside (-40.5% average return), the market may be pricing in unsustainable growth. Model dispersion is worth noting: Dynamic NAV targets $44.71 (+127.9%), versus ML-RIV at $0.00 (-100.0%). This +227.9% range highlights the importance of multi-model analysis rather than relying on any single methodology.
What Do the Models Say About AAPG?
12 of 13 models are currently active for AAPG. Of these, 2 models suggest upside while 10 models suggest overvaluation. The Bayesian DCF estimates AAPG's intrinsic value at $6.55, implying -66.6% downside from the current price. See which stocks rank higher →
How Does AAPG Rank in Biotechnology?
Among 62 Biotechnology stocks, AAPG ranks #24 by Quality of Company score. CirclFi's QOC score of 5.1/10 evaluates 32 fundamental signals. A score of 5.1 reflects mixed fundamentals.
See all Most Undervalued Biotechnology Stocks →
As a biotechnology enterprise, Ascentage Pharma Group Internat operates in a sector where pipeline depth and stage distribution is a critical driver of valuation. Investors evaluating AAPG should weigh these sector-specific dynamics alongside our model-derived fair values.
Is AAPG a Value Trap?
The Value Trap algorithm is not active for AAPG. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
12 of 13 models are active for Ascentage Pharma Group Internat. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi 32-factor quality framework, Ascentage Pharma Group Internat's fundamental quality profile registers 5.1/10. This mixed score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.
The gap between the most bullish and bearish model spans +227.9% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every AAPG valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across AAPG's 12 active models, average confidence is 14%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad